Navigation Links
News briefs from the January issue of Chest
Date:1/3/2011

DATA SHOWS OMALIZUMAB SAFE AND EFFECTIVE FOR MODERATE TO SEVERE ASTHMA

New research suggests that subcutaneous omalizumab is safe and effective an add-on treatment to corticosteroids for moderate to severe asthma in children and adults. Researchers from Uruguay, Argentina, and Chile performed a meta-analysis on eight trials where 1,883 patients received omalizumab and 1,546 received a placebo. At the end of the steroid reduction phase, patients taking omalizumab were more likely to have corticosteroids withdrawn completely compared with those taking placebo. Furthermore, patients taking omalizumab showed a decreased risk for asthma exacerbations at the end of stable and adjustable-steroid phase. The frequency of serious adverse events effects was similar between both groups, and there were no indications of increased risk of hypersensitivity reactions, cardiovascular effects, and malignant neoplasms. This article is published in the January issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(1):28-35.

SIMULATION TRAINING LINKED TO DECREASED CATHETER INFECTION

New research shows that simulation-based training in sterile techniques during central vein catheterization (CVC) is associated with decreased rate of catheter-related bloodstream infection (CRBSI). Over 1 year, researchers from St. Luke's-Roosevelt Hospital Center in New York randomly assigned 47 second and third-year internal medicine residents to simulation-based training plus video training or video training alone, with a follow-up period to examine CRBSI 6 months later. During the follow-up period, a simulation-based training program in sterile techniques during CVC was implemented in the medical intensive care unit (MICU). Residents' scores in sterile techniques and CRBSI rates were compared with residents in the surgical intensive care unit (SICU) who did not receive simulation training. Baseline scores from both groups were 12.5 to 13 out of a maximum score of 24. After training, the median score for the simulation group was 22, compared with 18 for the video training-only group. During follow up, there was a 70 percent reduction in the incidence of CRBSI in the postintervention MICU compared with the preintervention MICU and the postintervention SICU. Researchers conclude that simulation-based training is superior to traditional training and video training, and it should be routinely used to reduce iatrogenic risk. This article is published in the January issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(1):80-87.

SARCOIDOSIS INCIDENCE PREVALENT AMONG BLACK WOMEN

A new study using the largest sample to date reports that black women in the US have the highest incidence of sarcoidosis, a chronic lung disease characterized by dyspnea, fatigue, and cough. Researchers from Boston University analyzed the incidence, prevalence, and clinical characteristics of sarcoidosis among 59,000 black women across the United States who were part of the Black Women's Health Study. At baseline, in 1995, there were 685 cases of sarcoidosis. However, over the follow-up through 2007, an additional 435 cases were reported, resulting in a prevalence of 2.0 percent among black women. The highest incidence of the disease was among women in their 40s, while the median age at diagnosis was 32 years. Researchers cite a need for the assessment of sarcoidosis risk factors among this population. The article is published in the January issue of Chest, the peer-reviewed journal of the American College of Chest Physicians: Chest 2011; 139(1):144-150.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. News briefs from the March issue of Chest
2. News briefs from the April issue of Chest
3. News briefs from the May issue of Chest
4. News briefs from the July issue of Chest
5. News briefs from the August issue of Chest
6. Chest news briefs: CPAP may cause facial changes
7. Majority of Americans Approve of President Obamas Handling of Afghanistan and National Security But Disapprove of Handling of Economic Issues, Per Franklin & Marshall College Poll With Hearst Television
8. American Red Cross Issues One-Month Progress Report for Haiti Earthquake
9. New study suggests stem cells sabotage their own DNA to produce new tissues
10. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
11. One in Two Children Has Chronic Health Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016  In a startling report released today, National ... by lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... of how states are tackling the worst drug crisis in recorded ... – Kentucky , New Mexico ... . Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: